Diabetes-related antibodies in euglycemic subjects

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 19, Issue 1, 2005, Pages 101-117

  Achenbach, Peter ^a   Ziegler, Anette G ^a  

^a Klinikum Schwabing   (Germany)

Author keywords

Autoantibody; Diagnosis; Pathogenesis; Prediction; Prevalence; Type 1 diabetes

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE ANTIBODY; INSULIN ANTIBODY; PROTEIN TYROSINE PHOSPHATASE;

ANTIBODY DETECTION; ANTIBODY SCREENING; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CELL TYPE; CELLULAR IMMUNITY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PATHOGENESIS; RISK FACTOR; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE;

AUTOANTIBODIES; BLOOD GLUCOSE; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; HUMANS; REFERENCE VALUES; RISK FACTORS;

EID: 13844275463     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beem.2004.11.009     Document Type: Article

References (62)

1. G.S. Eisenbarth P.A. Gottlieb Autoimmune polyendocrine syndromes N Engl J Med 350 2004 2068-2079
2. M.A. Atkinson G.S. Eisenbarth Type 1 diabetes: New perspectives on disease pathogenesis and treatment Lancet 358 2001 221-229
3. S.M. Lieberman T.P. DiLorenzo A comprehensive guide to antibody and T-cell responses in type 1 diabetes Tissue Antigens 62 2003 359-377
4. M. Solimena Vesicular autoantigens of type 1 diabetes Diabetes Metab Rev 14 1998 227-240
5. U. Roll C.W. Turck S.E. Gitelman S.M. Rosenthal M.S. Nolte U. Masharani A.G. Ziegler S. Baekkeskov Peptide mapping and characterisation of glycation patterns of the glima 38 antigen recognised by autoantibodies in Type I diabetic patients Diabetologia 43 2000 598-608
6. B.O. Roep The role of T-cells in the pathogenesis of Type 1 diabetes: from cause to cure Diabetologia 46 2003 305-321
7. N. Itoh T. Hanafusa A. Miyazaki J. Miyagawa K. Yamagata K. Yamamoto M. Waguri A. Imagawa S. Tamura M. Inada et al. Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients J Clin Invest 92 1993 2313-2322
8. + T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors Diabetes 42 1993 44-55
9. D.V. Serreze H.D. Chapman D.S. Varnum M.S. Hanson P.C. Reifsnyder S.D. Richard S.A. Fleming E.H. Leiter L.D. Shultz B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: Analysis of a new 'speed congenic' stock of NOD.Ig mu null mice J Exp Med 184 1996 2049-2053
10. R.K. Sibley D.E. Sutherland F. Goetz A.F. Michael Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases Lab Invest 53 1985 132-144
11. S. Martin D. Wolf-Eichbaum G. Duinkerken W.A. Scherbaum H. Kolb J.G. Noordzij B.O. Roep Development of type 1 diabetes despite severe hereditary B-lymphocyte deficiency N Engl J Med 345 2001 1036-1040
12. S.A. Greeley M. Katsumata L. Yu G.S. Eisenbarth D.J. Moore H. Goodarzi C.F. Barker A. Naji H. Noorchashm Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice Nat Med 8 2002 399-402
13. K. Koczwara E. Bonifacio A.G. Ziegler Transmission of maternal islet antibodies and risk of autoimmune diabetes in offspring of mothers with type 1 diabetes Diabetes 53 2004 1-4
14. J.H. Warram A.S. Krolewski M.S. Gottlieb C.R. Kahn Differences in risk of insulin-dependent diabetes in offspring of diabetic mothers and diabetic fathers N Engl J Med 311 1984 149-152
15. P.J. Bingley E. Bonifacio P.W. Mueller Diabetes antibody standardization program: First assay proficiency evaluation Diabetes 52 2003 1128-1136
16. R. Turner I. Stratton V. Horton S. Manley P. Zimmet I.R. Mackay M. Shattock G.F. Bottazzo R. Holman UKPDS 25: Autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group Lancet 350 1997 1288-1293
17. M. Fuchtenbusch K. Ferber E. Standl A.G. Ziegler Prediction of type 1 diabetes postpartum in patients with gestational diabetes mellitus by combined islet cell autoantibody screening: A prospective multicenter study Diabetes 46 1997 1459-1467
18. P.J. Bingley E. Bonifacio A.G. Ziegler D.A. Schatz M.A. Atkinson G.S. Eisenbarth Proposed guidelines on screening for risk of type 1 diabetes Diabetes Care 24 2001 398
19. E. Bonifacio P.J. Bingley Islet autoantibodies and their use in predicting insulin-dependent diabetes Acta Diabetol 34 1997 185-193
20. H.E. Naserke N. Dozio A.G. Ziegler E. Bonifacio Comparison of a novel micro-assay for insulin autoantibodies with the conventional radiobinding assay Diabetologia 41 1998 681-683
21. P. Vardi A.G. Ziegler J.H. Mathews S. Dib R.J. Keller A.T. Ricker J.I. Wolfsdorf R.D. Herskowitz A. Rabizadeh G.S. Eisenbarth et al. Concentration of insulin autoantibodies at onset of type I diabetes. Inverse log-linear correlation with age Diabetes Care 11 1988 736-739
22. P.J. Bingley A.J. Williams E.A. Gale Optimized autoantibody-based risk assessment in family members. Implications for future intervention trials Diabetes Care 22 1999 1796-1801
23. C.F. Verge R. Gianani E. Kawasaki L. Yu M. Pietropaolo R.A. Jackson H.P. Chase G.S. Eisenbarth Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies Diabetes 45 1996 926-933
24. P. Kulmala K. Savola J.S. Petersen P. Vahasalo J. Karjalainen T. Lopponen T. Dyrberg H.K. Akerblom M. Knip Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. The Childhood Diabetes in Finland Study Group J Clin Invest 101 1998 327-336
25. K. Decochez I.H. de Leeuw B. Keymeulen C. Mathieu R. Rottiers I. Weets E. Vandemeulebroucke I. Truyen L. Kaufman F.C. Schuit et al. IA-2 autoantibodies predict impending Type I diabetes in siblings of patients Diabetologia 45 2002 1658-1666
26. J. Dittler D. Seidel M. Schenker A.G. Ziegler GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives Diabetes 47 1998 592-597
27. J.P. Krischer D.D. Cuthbertson L. Yu T. Orban N. Maclaren R. Jackson W.E. Winter D.A. Schatz J.P. Palmer G.S. Eisenbarth Screening strategies for the identification of multiple antibody-positive relatives of individuals with type 1 diabetes J Clin Endocrinol Metab 88 2003 103-108
28. H.E. Naserke M. Schenker A.G. Ziegler Frequency of islet autoantibodies in relatives of patients with Type II diabetes or gestational diabetes Diabetologia 42 1999 1377
29. D. Schatz J. Krischer G. Horne W. Riley R. Spillar J. Silverstein W. Winter A. Muir D. Derovanesian S. Shah et al. Islet cell antibodies predict insulin-dependent diabetes in United States school age children as powerfully as in unaffected relatives J Clin Invest 93 1994 2403-2407
30. J.M. LaGasse M.S. Brantley N.J. Leech R.E. Rowe S. Monks J.P. Palmer G.T. Nepom D.K. McCulloch W.A. Hagopian Successful prospective prediction of type 1 diabetes in schoolchildren through multiple defined autoantibodies: An 8-year follow-up of the Washington state diabetes prediction study Diabetes Care 25 2002 505-511
31. M. Strebelow M. Schlosser B. Ziegler I. Rjasanowski M. Ziegler Karlsburg Type I diabetes risk study of a general population: Frequencies and interactions of the four major Type I diabetes-associated autoantibodies studied in 9419 schoolchildren Diabetologia 42 1999 661-670
32. P.J. Bingley E. Bonifacio A.J. Williams S. Genovese G.F. Bottazzo E.A. Gale Prediction of IDDM in the general population: Strategies based on combinations of autoantibody markers Diabetes 46 1997 1701-1710
33. G.S. Eisenbarth Type I diabetes mellitus. A chronic autoimmune disease N Engl J Med 314 1986 1360-1368
34. A.G. Ziegler M. Hummel M. Schenker E. Bonifacio Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: The 2-year analysis of the German BABYDIAB study Diabetes 48 1999 460-468
35. T. Kimpimaki A. Kupila A.M. Hamalainen M. Kukko P. Kulmala K. Savola T. Simell P. Keskinen J. Ilonen O. Simell et al. The first signs of beta-cell autoimmunity appear in infancy in genetically susceptible children from the general population: The Finnish Type 1 Diabetes Prediction and Prevention Study J Clin Endocrinol Metab 86 2001 4782-4788
36. J.M. Barker K.J. Barriga L. Yu D. Miao H.A. Erlich J.M. Norris G.S. Eisenbarth M. Rewers Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes autoimmunity study in the young (DAISY) J Clin Endocrinol Metab 89 2004 3896-3902
37. P.G. Colman C. Steele J.J. Couper S.J. Beresford T. Powell K. Kewming A. Pollard S. Gellert B. Tait M. Honeyman et al. Islet autoimmunity in infants with a Type I diabetic relative is common but is frequently restricted to one autoantibody Diabetologia 43 2000 203-209
38. M. Hummel E. Bonifacio S. Schmid M. Walter A. Knopff A.G. Ziegler Brief communication: Early appearance of islet autoantibodies predicts childhood type 1 diabetes in offspring of diabetic parents Ann Intern Med 140 2004 882-886
39. T. Kimpimaki P. Kulmala K. Savola A. Kupila S. Korhonen T. Simell J. Ilonen O. Simell M. Knip Natural history of beta-cell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited from the general population J Clin Endocrinol Metab 87 2002 4572-4579
40. E. Bonifacio V. Lampasona L. Bernasconi A.G. Ziegler Maturation of the humoral autoimmune response to epitopes of GAD in preclinical childhood type 1 diabetes Diabetes 49 2000 202-208
41. H.E. Naserke A.G. Ziegler V. Lampasona E. Bonifacio Early development and spreading of autoantibodies to epitopes of IA-2 and their association with progression to type 1 diabetes J Immunol 161 1998 6963-6969
42. K. Savola E. Laara P. Vahasalo P. Kulmala H.K. Akerblom M. Knip Dynamic pattern of disease-associated autoantibodies in siblings of children with type 1 diabetes: A population-based study Diabetes 50 2001 2625-2632
43. H.E. Naserke E. Bonifacio A.G. Ziegler Prevalence, characteristics and diabetes risk associated with transient maternally acquired islet antibodies and persistent islet antibodies in offspring of parents with type 1 diabetes J Clin Endocrinol Metab 86 2001 4826-4833
44. E. Bonifacio M. Scirpoli K. Kredel M. Fuchtenbusch A.G. Ziegler Early autoantibody responses in prediabetes are IgG1 dominated and suggest antigen-specific regulation J Immunol 163 1999 525-532
45. P. Achenbach K. Koczwara A. Knopff H. Naserke A.G. Ziegler E. Bonifacio Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetes J Clin Invest 114 2004 589-597
46. A.M. Hamalainen M.S. Ronkainen H.K. Akerblom M. Knip Postnatal elimination of transplacentally acquired disease-associated antibodies in infants born to families with type 1 diabetes. The finnish TRIGR study group. Trial to reduce IDDM in the genetically at risk J Clin Endocrinol Metab 85 2000 4249-4253
47. E. Bonifacio P.J. Bingley M. Shattock B.M. Dean D. Dunger E.A. Gale G.F. Bottazzo Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes Lancet 335 1990 147-149
48. P.J. Bingley Interactions of age, islet cell antibodies, insulin autoantibodies, and first-phase insulin response in predicting risk of progression to IDDM in ICA+relatives: The ICARUS data set. Islet cell antibody register users study Diabetes 45 1996 1720-1728
49. P.J. Bingley M.R. Christie E. Bonifacio R. Bonfanti M. Shattock M.T. Fonte G.F. Bottazzo E.A. Gale Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives Diabetes 43 1994 1304-1310
50. N. Maclaren M. Lan R. Coutant D. Schatz J. Silverstein A. Muir M. Clare-Salzer J.X. She J. Malone S. Crockett et al. Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2beta predict immune-mediated (Type 1) diabetes in relatives J Autoimmun 12 1999 279-287
51. P. Achenbach K. Warncke J. Reiter H.E. Naserke A.J. Williams P.J. Bingley E. Bonifacio A.G. Ziegler Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics Diabetes 53 2004 384-392
52. M.R. Christie S. Genovese D. Cassidy E. Bosi T.J. Brown M. Lai E. Bonifacio G.F. Bottazzo Antibodies to islet 37k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity Diabetes 43 1994 1254-1259
53. M.J. Redondo G.S. Eisenbarth Genetic control of autoimmunity in Type I diabetes and associated disorders Diabetologia 45 2002 605-622
54. J. Graham W.A. Hagopian I. Kockum L.S. Li C.B. Sanjeevi R.M. Lowe J.B. Schaefer M. Zarghami H.L. Day M. Landin-Olsson et al. Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes Diabetes 51 2002 1346-1355
55. P. Kulmala K. Savola H. Reijonen R. Veijola P. Vahasalo J. Karjalainen E. Tuomilehto-Wolf J. Ilonen J. Tuomilehto H.K. Akerblom et al. Genetic markers, humoral autoimmunity, and prediction of type 1 diabetes in siblings of affected children. Childhood diabetes in finland study group Diabetes 49 2000 48-58
56. M. Schenker M. Hummel K. Ferber M. Walter E. Keller E.D. Albert H.U. Janka C. Kastendiek M. Sorger F. Louwen et al. Early expression and high prevalence of islet autoantibodies for DR3/4 heterozygous and DR4/4 homozygous offspring of parents with Type I diabetes: The German BABYDIAB study Diabetologia 42 1999 671-677
57. J. Yu L. Yu T.L. Bugawan H.A. Erlich K. Barriga M. Hoffman M. Rewers G.S. Eisenbarth Transient antiislet autoantibodies: Infrequent occurrence and lack of association with 'genetic' risk factors J Clin Endocrinol Metab 85 2000 2421-2428
58. S.T. Bennett A.M. Lucassen S.C. Gough E.E. Powell D.E. Undlien L.E. Pritchard M.E. Merriman Y. Kawaguchi M.J. Dronsfield F. Pociot et al. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus Nat Genet 9 1995 284-292
59. D. Mathis C. Benoist Back to central tolerance Immunity 20 2004 509-516
60. M. Walter E. Albert M. Conrad E. Keller M. Hummel K. Ferber B.J. Barratt J.A. Todd A.G. Ziegler E. Bonifacio IDDM2/insulin VNTR modifies risk conferred by IDDM1/HLA for development of Type 1 diabetes and associated autoimmunity Diabetologia 46 2003 712-720
61. M. Hummel A.G. Ziegler R. Roth Psychological impact of childhood islet autoantibody testing in families participating in the BABYDIAB study Diabet Med 21 2004 324-328
62. S.B. Johnson Screening programs to identify children at risk for diabetes mellitus: Psychological impact on children and parents J Pediatr Endocrinol Metab 14 supplement 1 2001 653-659